MARKET EYE-SGX Nifty gains after firm China PMI

Mon Dec 3, 2012 8:38am IST

Related Topics

* Nifty futures on the Singapore Exchange rise 0.1
percent. The MSCI-Asia Pacific index excluding Japan
 is up 0.29 percent.      
* Asian shares edged higher on Monday as further signs of a
stabilising Chinese economy boosted sentiment, but stagnant U.S.
budget talks which threaten to derail the world's largest
economy kept investors cautious and capped prices.  
  
* Foreign investors bought 16.11 billion rupees of stocks, while
domestic institutions sold 7.98 billion rupees on Friday, when
the BSE index rose 0.88 percent.  
* Two key regional allies of India's Congress party, the Bahujan
Samaj Party (BSP) and the Samajwadi Party (SP) will hold
separate meetings in Delhi on Monday ahead of a vote in 
parliament on supermarket reform which is expected to be held on
Wednesday.
* India's stuttering economic reform programme faces a key
parliamentary test this week on whether to let foreign
supermarket chains such as Wal-Mart Stores set up shop,
in a vote that could pave the way for further measures to revive
the economy. 
* Also on watch, India's manufacturing PMI for November at 0500
GMT.

 (abhishek.vishnoi@thomsonreuters.com /;
abhishek.vishnoi.reuters.com@reuters.net)
FILED UNDER:

Monetary Policy Committee

Reuters Showcase

Microfinance

Microfinance

Funding the unfunded: India helps small business borrow to grow  Full Article 

Insurance Sector

Insurance Sector

UK healthcare firm Bupa sees strong growth in India  Full Article 

Sensex Rises

Sensex Rises

Sensex edges up; consumer and healthcare stocks rise  Full Article 

Market Eye

Market Eye

FTSE adds nine Indian firms as large-caps in Asia-Pacific ex-Japan index   Full Article 

Indian Ocean Diplomacy

Indian Ocean Diplomacy

PM Modi to ramp up help for Indian Ocean nations to counter China influence  Full Article 

ECB Bond-Buying

ECB Bond-Buying

ECB raises growth forecasts, to start printing money next week  Full Article 

China Economy

China Economy

China signals "new normal" with lower annual growth target  Full Article 

Pharma Sector

Pharma Sector

Panel recommends waiving late-stage trials for some drugs  Full Article 

E-commerce

E-commerce

China backs e-commerce expansion in win for Alibaba, JD.com  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device  Full Coverage